2.3.1.39	Aberrant Crypt Foci	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19173288&form=6&db=m	Fatty acid synthase is over-expressed in large aberrant crypt foci in rats treated with azoxymethane.	causal interaction,therapeutic application,unassigned	3,1,0	
2.3.1.39	Aberrant Crypt Foci	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19358283&form=6&db=m	Increased expression of fatty acid synthase in human aberrant crypt foci: possible target for colorectal cancer prevention.	causal interaction,diagnostic usage,unassigned	3,3,0	
2.3.1.39	Acidosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15523670&form=6&db=m	In support of fatty acid synthase (FAS) as a metabolic oncogene: extracellular acidosis acts in an epigenetic fashion activating FAS gene expression in cancer cells.	causal interaction,ongoing research,unassigned	1,3,0	
2.3.1.39	Acute Coronary Syndrome	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22490687&form=6&db=m	[Effects of soluble epoxide hydrolase inhibitors on the expression of fatty acid synthase in peripheral blood mononuclear cell of patients and inflammatory response with acute coronary syndrome].	diagnostic usage,ongoing research,unassigned	3,4,0	
2.3.1.39	Acute Coronary Syndrome	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23305094&form=6&db=m	Effects of soluble epoxide hydrolase inhibitor on the expression of fatty acid synthase in peripheral blood mononuclear cell in patients with acute coronary syndrome.	causal interaction,diagnostic usage,ongoing research,therapeutic application	4,3,4,4	
2.3.1.39	Acute Lung Injury	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31287803&form=6&db=m	Fatty acid synthase downregulation contributes to acute lung injury in murine diet-induced obesity.	causal interaction,ongoing research,therapeutic application,unassigned	4,2,2,0	
2.3.1.39	Adenocarcinoma	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6130760&form=6&db=m	Studies on acetyl-CoA carboxylase and fatty acid synthase from rat mammary gland and mammary tumours.	ongoing research,therapeutic application,unassigned	4,1,0	
2.3.1.39	Adenocarcinoma	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11176534&form=6&db=m	Fatty acid synthase: an early molecular marker of progression of prostatic adenocarcinoma to androgen independence.	causal interaction,diagnostic usage,ongoing research,therapeutic application	4,3,3,1	
2.3.1.39	Adenocarcinoma	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15051923&form=6&db=m	Liver-type fatty acid-binding protein is highly expressed in intestinal metaplasia and in a subset of carcinomas of the stomach without association with the fatty acid synthase status in the carcinoma.	causal interaction,diagnostic usage,ongoing research,therapeutic application	3,3,3,1	
2.3.1.39	Adenocarcinoma	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15094777&form=6&db=m	Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.	causal interaction,diagnostic usage,ongoing research,therapeutic application	4,3,2,1